Clincosm LogoSign in Get a demo

non small cell lung cancer

Showing 1 - 25 of 769
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Non Small Cell Lung Cancer Trial in China (Efgbemalenograstim alfa)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Efgbemalenograstim alfa
  • Zhengzhou, Henan, China
  • +9 more
Nov 16, 2023

Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Peking, China
    Peking Union Medical College Hospital
Nov 16, 2023

Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Standard systemic therapy + radiotherapy
  • Standard systemic therapy
  • Gothenburg, Sweden
  • +5 more
Nov 17, 2023

Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • carboplatin chemotherapy
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 3, 2023

Wearable Smart Devices in Perioperative NSCLC Patients

Recruiting
  • Non Small Cell Lung Cancer
  • Wearable smart devices and PROs
  • Guangzhou, Guangdong, China
    Department of Thoracic Surgery and Oncology, The First Affiliate
Nov 3, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

LMV-12 Combined With Osimertinib in NSCLC

Not yet recruiting
  • Non Small Cell Lung Cancer
  • LMV-12(HE003) and Osimertinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 25, 2023

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

Specific Protein Overexpression in Adult Non-Small Cell Lung

Not yet recruiting
  • Non Small Cell Lung Cancer
    • (no location specified)
    Sep 29, 2023

    Non Small Cell Lung Cancer, Non-small Cell Carcinoma Trial in Belgium (Physical activity tele coaching program)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Non-small Cell Carcinoma
    • Physical activity tele coaching program
    • Genk, Limburg, Belgium
    • +5 more
    Sep 28, 2023

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Plasma ctDNA
    • FFPE blocks
    • Angers, France
    • +35 more
    Sep 19, 2023

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Using Urine Samples to Identify Lung Cancer

    Recruiting
    • Non Small Cell Lung Cancer
    • urine sample
    • Basking Ridge, New Jersey
    • +6 more
    Sep 5, 2023

    Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • CTV omitted or delineated
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Sep 1, 2023

    Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Aug 31, 2023

    Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Middletown, New Jersey
    • +5 more
    Aug 17, 2023

    EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

    Not yet recruiting
    • EGF-R Positive Non-Small Cell Lung Cancer
    • +4 more
    • Stereotactic Body Radiation Therapy SBRT
    • Bogotá, Colombia
      CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
    Aug 16, 2023

    Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Port Saint Lucie, Florida
    • +1 more
    Aug 11, 2023

    Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Propranolol
    • Propranolol hydrochloride
    • +2 more
    • (no location specified)
    Jul 31, 2023

    PET-CT Predicting Segement Specific Lymph Nodes Metastasis

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
      • Shanghai, China
        Shanghai Cancer Center
      Jul 23, 2023

      Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

      Not yet recruiting
      • Head and Neck Cancer
      • +9 more
      • (no location specified)
      Jul 12, 2023